PolyNovo Limited (ASX: PNV) ABN 96 083 866 862 2/320 Lorimer Street, Port Melbourne, Victoria 3207 Australia +61 3 8681 4050 [email protected] investors.polynovo.com 17 August 2026 ASX Announcement PolyNovo FY26 Results Presentation: Registration Details ...
PolyNovo FY26 Results Presentation - Registration Details
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Shareholders must register in advance to access the webcast and can submit questions before or during the event. The announcement has been authorized by the Company Secretary, Amy Demediuk. PolyNovo is a medical technology company focused on transforming wound management and has operations in multiple countries.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Story so far
Earlier from PolyNovo
- Becoming a substantial holder
- PolyNovo FY26 Trading Update
- Response to ASX Price Query
- Appendix 4D & H1 FY26 Financial Statements
- 1H FY26 Results Presentation
Later from PolyNovo
- Ceasing to be a substantial holder
- ASX Announcement - FY26 Full Year Results
- FY26 Full Year Results Investor Presentation
- FY26 Full Year Results and Appendix 4E
- PolyNovo FY26 Results Presentation Webinar Recording
Follow PolyNovo into a list and get an email when it puts out news.
Follow PolyNovo
